Drug Trial Radar · NCT07188805
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
111
Planned (sponsor's estimate)
Start
Nov 19, 2025
Primary completion
Nov 30, 2029
Study completion Dec 30, 2029
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Sep 23, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 months, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Researchers are looking for a better way to treat children who have heart failure with left ventricular systolic dysfunction (LVSD). Heart failure is a serious condition where the heart is unable to pump enough blood to meet the body's needs. This can lead to symptoms like shortness of breath, fatigue, and poor growth in children. The study treatment, finerenone (also called BAY94-8862), works by blocking a protein involved in inflammation, scarring, and thickening of the heart and blood vessels. This may help the heart to pump blood more effectively. This is the first study to explore its use specifically for children with heart failure and LVSD. The main purpose of this study is to learn if finerenone works to help the heart compared to placebo in children with heart failure and LVSD. For this, the researchers will collect and analyze data on the levels of a protein called NT-proBNP in the blood, which indicates heart stress, and monitor the safety of the treatment. The study will include children with heart failure and LVSD aged from 6 months to less than 18 years. The study participants will be randomly assigned to one of two treatment groups. Based on their group, they will receive either finerenone or a placebo for a duration of 3 months. A placebo looks like a treatment but does not have any medicine in it. Throughout the study, all participants will continue to receive their standard heart failure treatments. At the start of this study, the doctors will check each participant's medical history and current medications. If participants qualify for the treatment phase, they will undergo treatment for about 90 days. During this time, they will visit the study site at least 3 times. During these visits, the participants will: * have their blood pressure, heart rate, temperature, respiratory rate, height and weight measured * have their heart examined by electrocardiogram (ECG) and echocardiogram * have blood samples taken * have physical examinations * answer questions about their medication and whether they have any adverse events, or have their parents or guardians' answers An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events that happen in studies, even if they do not think the adverse events might be related to the study treatments. After the initial three-month study, eligible participants will have the option to join a nine-month open-label extension study where all will receive finerenone. Participants who choose not to enroll in the extension will have a follow-up visit 30 days after their last treatment.
Conditions
- Left Ventricular Systolic Dysfunction
- Heart Failure (Pediatric)
Interventions
Finerenone (Kerendia, BAY94-8862)Drug
Finerenone in different doses, treatment duration will be 90±3 days
PlaceboDrug
Placebo to finerenone, treatment duration will be 90±3 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in NT-proBNP levelsTime frame: From baseline to Day 90±3
Locations
133 sites in 23 countries. Site status is shown where the registry gives one.
Children's Hospital Colorado - Anschutz Medical Campus - Cardiology
Aurora, Colorado · Not yet recruiting
Nemours Children's Hospital - Delaware - Cardiology
Wilmington, Delaware · Not yet recruiting
UF Health Shands Hospital - Pediatric Cardiology
Gainesville, Florida · Not yet recruiting
Joe Dimaggio Children's Hospital - Cardiology
Hollywood, Florida · Not yet recruiting
Emory University Hospital - Children's Healthcare of Atlanta Cardiology - Atlanta
Atlanta, Georgia · Not yet recruiting
Riley Hospital For Children - Cardiology
Indianapolis, Indiana · Not yet recruiting
Boston Children's Hospital - Main Campus - Cardiology
Boston, Massachusetts · Not yet recruiting
C.S. Mott Children's Hospital - Cardiology
Ann Arbor, Michigan · Not yet recruiting
Children's Mercy Hospital Kansas City - Cardiology
Kansas City, Missouri · Not yet recruiting
Washington University - St. Louis Children's Hospital - Cardiology
St Louis, Missouri · Not yet recruiting
Icahn School of Medicine at Mount Sinai - Pediatric Cardiology
New York, New York · Not yet recruiting
Columbia University Irving Medical Center - Pediatric Cardiology
New York, New York · Not yet recruiting
The Children's Hospital at Montefiore - Cardiology
The Bronx, New York · Not yet recruiting
Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension
Cincinnati, Ohio · Not yet recruiting
Cleveland Clinic Children's
Cleveland, Ohio · Not yet recruiting
Nationwide Children's Hospital - Cardiology
Columbus, Ohio · Not yet recruiting
Children's Hospital of Philadelphia - Cardiology
Philadelphia, Pennsylvania · Not yet recruiting
UPMC Children's Hospital of Pittsburgh - Cardiology
Pittsburgh, Pennsylvania · Not yet recruiting
MUSC Shawn Jenkins Children's Hospital - Cardiology
North Charleston, South Carolina · Not yet recruiting
Children's Medical Center Dallas - Cardiology
Dallas, Texas · Not yet recruiting
Texas Children's Hospital - Cardiology
Houston, Texas · Not yet recruiting
Eccles Primary Children's Outpatient Services - Cardiology
Salt Lake City, Utah · Not yet recruiting
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina · Not yet recruiting
Hospital General de Ninos Pedro de Elizalde | Nephrology Department
Ciudad Autonoma de Buenos Aire, Argentina · Not yet recruiting
Consultorios Médicos Dr. Doreski
Ciudad Autónoma de Buenos Aire, Argentina · Not yet recruiting
Sanatorio de la Cañada
Córdoba, Argentina · Not yet recruiting
Centro Cardiovascular Salta (Torzav SRL)
Salta, Argentina · Not yet recruiting
Hospital de Pediatría Juan P. Garrahan
Buenos Aires, Buenos Aires, Argentina · Not yet recruiting
Hospital de Niños Sor María Ludovica
La Plata, Buenos Aires, Argentina · Not yet recruiting
Instituto De Investigaciones Clinicas Zarate | Zarate, Argentina
Zárate, Buenos Aires, Argentina · Recruiting
Hospital General de Ninos Ricardo Gutierrez | Cardiology Department
Buenos Aires, Ciudad Auton. de Buenos Aires, Argentina · Not yet recruiting
Consultorios Integrados Rosario | Instituto Medico de la Fundacion de Estudios Clinicos
Rosario, Santa Fe Province, Argentina · Not yet recruiting
Medizinische Universität Wien - Klinik für Kinder- und Jugendheilkunde, Abteilung für Pädiatrische Kardiologie
Vienna, State of Vienna, Austria · Not yet recruiting
Kepler Universitätsklinikum GmbH - Klinik für Kinderkardiologie
Innsbruck, Upper Austria, Austria · Not yet recruiting
Cliniques Universitaires St-Luc (UCL) - Pediatric Cardiology
Brussels, Belgium · Recruiting
UZ Antwerpen - Pediatric Cardiology
Edegem, Belgium · Not yet recruiting
UZ Gent - Pediatric Cardiology
Ghent, Belgium · Not yet recruiting
CHC MontLegia - Pediatric Cardiology
Liège, Belgium · Not yet recruiting
UZ Leuven - Pediatric Cardiology
Leuven, Flemish Brabant, Belgium · Not yet recruiting
Hospital de Clínicas da Universidade Federal de Uberlândia Empresa Brasileira de Serviços Hospitalares - EBSERH
Uberlândia, Minas Gerais, Brazil · Withdrawn
Showing 40 of 133 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.